Mike Conlon
PhD
Epidemiology and Biostatistics
Advanced Medical Research Institute of Canada
Canada
Biography
Dr. Mike Conlon was born and raised in Sudbury. He received a BSc degree from the University of Western Ontario, a MSc from Laurentian University, and a PhD in Epidemiology and Biostatistics from the University of Western Ontario. Dr. Conlon has been conducting cancer research at the Northeast Cancer Center for 20 years and in 2008 became the Director of the Epidemiology, Outcomes, and Evaluation at Health Sciences North’s Northeast Cancer Center. Dr. Conlon and his team’s studies include traditional survey-based research, laboratory-based genetics, and health services research. The studies are large, diverse, and often collaborative in nature, with other researchers and clinicians at local, national, and international levels. Scientific findings are translated at scientific forums and published in scientific journals. Dr. Conlon’s primary research focus includes examining risk factors for disease and treatment-based outcomes that are important in residents of the Northeast, and also explores important access to care issues in northeastern Ontario populations. Some of the projects involve, the analyses of biological samples obtained from an individual’s saliva, blood or tissues, which may help researchers and clinicians better tailor personal outcomes.
Research Interest
Epidemiology and Biostatistics, Genetics
Publications
-
Conlon MS, Bewick MA. (2011) Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada. Nicotine Tob Res. 13(11):1076-83
-
Migliorati CA, Saunders D, Conlon MS, Ingstad HK, Vaagen P, Palazzolo MJ, Herlofson BB.( 2013) Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction. J Am Dent Assoc. 144(4):406-14.
-
Conlon M, Hartman M, Ballantyne B, Aubin N, Meigs M, Knight A. (2015) Access to oncology consultation in a cancer cohort in northeastern Ontario. Curr Oncol. 22(2)
